First Circuit Courts Heated Debate on 340B Subsidy Lawsuit
The First Circuit hears a lawsuit challenging federal subsidy allocations to nearly half the states.
Why it matters: This case could reshape funding for low-income healthcare providers, impacting millions who rely on their services. Its outcome may set important legal precedents for future healthcare funding disputes.
- The First Circuit is reviewing a federal lawsuit over subsidy allocations impacting nearly half the U.S. states.
- In January 2026, the court denied a government motion to stay a ruling halting the 340B Rebate Model Pilot Program.
- The 340B Rebate Model Pilot Program, launched July 31, 2025, proposed shifting drug discounts to a rebate system for safety-net hospitals.
- The American Hospital Association and hospitals challenged the program, citing ignored reliance interests and financial burdens.
The First Circuit Court of Appeals is currently hearing arguments in a significant federal lawsuit concerning the allocation of subsidies to low-income healthcare providers across nearly half the states. This legal battle centers on the Department of Health and Human Services' (HHS) 340B Rebate Model Pilot Program.
Announced on July 31, 2025, the 340B Rebate Model Pilot Program proposed moving from upfront drug discounts to a rebate system for outpatient drugs provided to safety-net hospitals that serve low-income patients. The shift aimed to alter how subsidies are distributed under the long-standing 340B Drug Pricing Program, which since 1992 has enabled eligible providers to purchase drugs at discounted prices.
The court denied the government's motion for a stay on January 7, 2026. This upheld a district court's preliminary injunction, which had halted the rebate program from moving forward during the appeal process.
The American Hospital Association (AHA) and various hospitals challenged the program, arguing it was "arbitrary and capricious" because it failed to consider the reliance interests of hospitals accustomed to upfront discounts. The AHA also raised concerns about the financial burdens the rebate system would impose, potentially disrupting the operational viability of these healthcare providers.
Rick Pollack, President and CEO of the AHA, said the First Circuit recognized the district court's decision as "careful and thorough" and correct in halting the program.
The outcome of this case could have significant implications for millions who rely on subsidized healthcare services, as well as influence how federal healthcare funding programs are structured going forward.
By the numbers:
- July 31, 2025 — Date the 340B Rebate Model Pilot Program was announced
- January 7, 2026 — First Circuit denied government motion to stay injunction halting the rebate program